At higher concentrations (5–10 μM), AMA suppressed the expression of two major signalling pathways that are often dysregulated in cancer cells, namely, Wnt/β-catenin and NF-κB (Figure 3(b)). This evidence concerns the gene NFKB1 and cancer.